Quote:

---

Being on OTC is main culprit, we have no credibility and SP only moves on major news. BLA, BTD approvals and License Deals seems only way to get us out of the OTC quicksand. Cancer news has virtually no impact on SP and now we can add coronavirus to the mix, does nothing to our SP

---

I hear you. And I agree with you.

We are a very small company still with no resources (revenue/money) listed in OTC with very little exposure to the "big market". We don't have institucional investors (THIS is for me is unbelievable at this stage) which have lots of free cash around precisely to take opportunities like this swiftly.

The only prospect of a drug that could work on ONE oncology application 5 years down the road would give a company a $2-$3 Billion valuation easily.

Not us. We have the firm promise of a working drug for Oncology, and the fact of a working one for HIV and can't take off. The reason ?? exposure (not financial credibility). Please keep in mind that there is only few thousands of us "small fish" buying/selling the stock.

We need to up list. Some of the walls of Institucional investors will fall then (the remaining wall will fall when stock price goes above $5 dollars).

So, let's keep out aim at one thing: Up Listing

BTW. I had promised myself that I had enough exposure to CYDY and sinned yesterday buying some more @ $1.03